AMED
Price
$93.89
Change
+$0.01 (+0.01%)
Updated
Jun 6 closing price
Capitalization
3.02B
46 days until earnings call
OPCH
Price
$31.90
Change
-$0.27 (-0.84%)
Updated
Jun 6 closing price
Capitalization
5.82B
53 days until earnings call
Interact to see
Advertisement

AMED vs OPCH

Header iconAMED vs OPCH Comparison
Open Charts AMED vs OPCHBanner chart's image
Amedisys
Price$93.89
Change+$0.01 (+0.01%)
Volume$151.61K
Capitalization3.02B
Option Care Health
Price$31.90
Change-$0.27 (-0.84%)
Volume$2.45M
Capitalization5.82B
AMED vs OPCH Comparison Chart
Loading...
AMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPCH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMED vs. OPCH commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a StrongBuy and OPCH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (AMED: $93.89 vs. OPCH: $31.90)
Brand notoriety: AMED and OPCH are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AMED: 45% vs. OPCH: 112%
Market capitalization -- AMED: $3.02B vs. OPCH: $5.82B
AMED [@Medical/Nursing Services] is valued at $3.02B. OPCH’s [@Medical/Nursing Services] market capitalization is $5.82B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $88.21B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $4.28B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMED’s FA Score shows that 0 FA rating(s) are green whileOPCH’s FA Score has 2 green FA rating(s).

  • AMED’s FA Score: 0 green, 5 red.
  • OPCH’s FA Score: 2 green, 3 red.
According to our system of comparison, OPCH is a better buy in the long-term than AMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMED’s TA Score shows that 5 TA indicator(s) are bullish while OPCH’s TA Score has 2 bullish TA indicator(s).

  • AMED’s TA Score: 5 bullish, 3 bearish.
  • OPCH’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, AMED is a better buy in the short-term than OPCH.

Price Growth

AMED (@Medical/Nursing Services) experienced а -0.19% price change this week, while OPCH (@Medical/Nursing Services) price change was -2.39% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +4.79%. For the same industry, the average monthly price growth was +6.57%, and the average quarterly price growth was +11.51%.

Reported Earning Dates

AMED is expected to report earnings on Jul 23, 2025.

OPCH is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (+4.79% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPCH($5.82B) has a higher market cap than AMED($3.02B). AMED has higher P/E ratio than OPCH: AMED (1170.50) vs OPCH (22.16). OPCH YTD gains are higher at: 37.500 vs. AMED (3.414). OPCH has higher annual earnings (EBITDA): 472M vs. AMED (129M). OPCH has more cash in the bank: 344M vs. AMED (126M). AMED has less debt than OPCH: AMED (487M) vs OPCH (1.17B). OPCH has higher revenues than AMED: OPCH (4.3B) vs AMED (2.24B).
AMEDOPCHAMED / OPCH
Capitalization3.02B5.82B52%
EBITDA129M472M27%
Gain YTD3.41437.5009%
P/E Ratio1170.5022.165,283%
Revenue2.24B4.3B52%
Total Cash126M344M37%
Total Debt487M1.17B42%
FUNDAMENTALS RATINGS
AMED vs OPCH: Fundamental Ratings
AMED
OPCH
OUTLOOK RATING
1..100
360
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
10030
SMR RATING
1..100
7653
PRICE GROWTH RATING
1..100
5448
P/E GROWTH RATING
1..100
5418
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMED's Valuation (73) in the Medical Or Nursing Services industry is in the same range as OPCH (78) in the null industry. This means that AMED’s stock grew similarly to OPCH’s over the last 12 months.

OPCH's Profit vs Risk Rating (30) in the null industry is significantly better than the same rating for AMED (100) in the Medical Or Nursing Services industry. This means that OPCH’s stock grew significantly faster than AMED’s over the last 12 months.

OPCH's SMR Rating (53) in the null industry is in the same range as AMED (76) in the Medical Or Nursing Services industry. This means that OPCH’s stock grew similarly to AMED’s over the last 12 months.

OPCH's Price Growth Rating (48) in the null industry is in the same range as AMED (54) in the Medical Or Nursing Services industry. This means that OPCH’s stock grew similarly to AMED’s over the last 12 months.

OPCH's P/E Growth Rating (18) in the null industry is somewhat better than the same rating for AMED (54) in the Medical Or Nursing Services industry. This means that OPCH’s stock grew somewhat faster than AMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMEDOPCH
RSI
ODDS (%)
Bearish Trend 1 day ago
45%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
49%
Bearish Trend 1 day ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 5 days ago
52%
Bullish Trend 8 days ago
67%
Declines
ODDS (%)
Bearish Trend 15 days ago
58%
Bearish Trend 3 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
49%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
AMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPCH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIDAX26.070.05
+0.19%
American Funds Income Fund of Amer R1
FIDPX10.73N/A
N/A
Federated Hermes Intl Dividend Strategy
GSGRX46.43N/A
N/A
Goldman Sachs Equity Income A
JDWAX119.67N/A
N/A
Janus Henderson Global Research A
NRICX21.90N/A
N/A
Nuveen Real Asset Income C

AMED and

Correlation & Price change

A.I.dvisor tells us that AMED and ENSG have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and ENSG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMED
1D Price
Change %
AMED100%
-0.72%
ENSG - AMED
25%
Poorly correlated
+0.45%
TALK - AMED
24%
Poorly correlated
+1.23%
OPCH - AMED
23%
Poorly correlated
-0.84%
BKD - AMED
22%
Poorly correlated
-0.30%
MD - AMED
21%
Poorly correlated
+1.22%
More

OPCH and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPCH has been loosely correlated with CHE. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if OPCH jumps, then CHE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPCH
1D Price
Change %
OPCH100%
-0.84%
CHE - OPCH
57%
Loosely correlated
+0.29%
DVA - OPCH
41%
Loosely correlated
+0.12%
USPH - OPCH
32%
Poorly correlated
+1.91%
MD - OPCH
29%
Poorly correlated
+1.22%
ADUS - OPCH
29%
Poorly correlated
+0.86%
More